Celecoxib inhibits CD133-positive cell migration via reduction of CCR2 in helicobacter pylori-infected mongolian gerbils

Digestion

Volumn 81, Issue 3, 2010, Pages 193-203

  Futagami, Seiji ^a   Hamamoto, Tatsuhiko ^a   Shimpuku, Mayumi ^a   Nagoya, Hiroyuki ^a   Kawagoe, Tetsuro ^a   Horie, Akane ^a   Shindo, Tomotaka ^a   Gudis, Katya ^a   Sakamoto, Choitsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Bone marrow derived cells; CD133 positive cell migration; Celecoxib; Helicobacter pylori infected gerbils; N Methyl N nitrosourea

Indexed keywords

CD133 ANTIGEN; CELECOXIB; CHEMOKINE RECEPTOR CCR2; METHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER TISSUE; CELL MIGRATION; CELLULAR DISTRIBUTION; CHRONIC GASTRITIS; CONTROLLED STUDY; DIET; DRUG INHIBITION; DRUG MECHANISM; EPITHELIUM CELL; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH EPITHELIUM; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CELL COUNT; CELL MOVEMENT; DISEASE PROGRESSION; EPITHELIAL CELLS; GASTRIC MUCOSA; GASTRITIS; GERBILLINAE; GLYCOPROTEINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNOHISTOCHEMISTRY; INCIDENCE; PEPTIDES; PYRAZOLES; RECEPTORS, CCR2; STOMACH NEOPLASMS; SULFONAMIDES; TISSUE DISTRIBUTION;

EID: 74249087041     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000252790     Document Type: Article

References (35)

1. Wang TC, Goldenring JR, Dangler C, Ito S, Mueller A, Jeon WK, Koh TJ, Fox JG: Mice lacking secretory phospholipase A 2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 1998; 114: 675-689.
2. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369-377.
3. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
4. Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, Sturgeon C, Hewett T, Chung T, Stock W, Sher D, Weissman S, Ferrer K, Mosca J, Deans R, Moseley A, Hoffman R: Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244-255.
5. Anderson DJ, Gage FH, Weissman IL: Can stem cells cross lineage boundaries? Nat Med 2001; 7: 393-395.
6. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J: The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007; 25: 1737-1745.
7. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC: Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568-1571.
8. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 5013-5021.
9. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
10. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951.
11. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110.
12. Kawamori T, Rao CV, Seibert K, Reddy BS: Chemopreventive activity of a celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58: 409-412.
13. Shimizu N, Ikehara Y, Inada K, Nakanishi H, Tsukamoto T, Nozaki K, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M: Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 2000; 60: 1512-1514.
14. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M: Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999; 20: 669-676. (Pubitemid 29151306)
15. Tatematsu M, Tsukamoto T, Mizoshita T: Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter 2005; 10: 97-106.
16. Handgretinger R, Gordon PR, Leimig T, Chen X, Buhring HJ, Niethammer D, Kuci S: Biology and plasticity of CD133+ hematopoietic stem cells. Ann NY Acad Sci 2003; 996: 141-151. (Pubitemid 36706596)
17. Larrivee B, Niessen K, Pollet I, Corbel SY, Long M, Rossi FM, Olive PL, Karsan A: Minimal contribution of bone marrow-derived endothelial precursors to tumor vasculature. J Immunol 2005; 175: 2890-2899.
18. Shmelkov SV, St Clair R, Lyden D, Rafii S: AC133/CD133/prominin-1. Int J Biochem Cell Biol 2005; 37: 715-719.
19. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012.
20. Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Gerber HP, Van Orden KL, Moore PA, Ruben SM, Carter PJ: CD133/ prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer 2008; 99: 100-109.
21. Cogle CR, Theise ND, Fu D, Ucar D, Lee S, Guthrie SM, Lonergan J, Rybka W, Krause DS, Scott EW: Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells 2007; 25: 1881-1887.
22. Avital I, Moreira AL, Klimstra DS, Leversha M, Papadopoulos EB, Brennan M, Downey RJ: Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation. Stem Cells 2007; 25: 2903-2909.
23. Ritter E, Perry A, Yu J, Wang T, Tang L, Bieberich E: Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells. Ann Surg 2008; 247: 310-314.
24. Widera D, Holtkamp W, Entschladen F, Niggemann B, Zanker K, Kaltschmidt B, Kaltschmidt C: MCP-1 induces migration of adult neural stem cells. Eur J Cell Biol 2004; 83: 381-387.
25. Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S: Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 2007; 27: 12396-12406.
26. Belema-Bedada F, Uchida S, Martire A, Kostin S, Braun T: Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell 2008; 2: 566-575.
27. Ito A, Suganami T, Yamauchi A, Degawa-Yamauchi M, Tanaka M, Kouyama R, Kobayashi Y, Nitta N, Yasuda K, Hirata Y, Kuziel WA, Takeya M, Kanegasaki S, Kamei Y, Ogawa Y: Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J Biol Chem 2008; 283: 35715-35723.
28. Futagami S, Hiratsuka T, Tatsuguchi A, Suzuki K, Kusunoki M, Shinji Y, Shinoki K, Iizumi T, Akamatsu T, Nishigaki H, Wada K, Miyake K, Gudis K, Tsukui T, Sakamoto C: MCP-1 released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells. Gut 2003; 52: 1257-1264.
29. Futagami S, Tatsuguchi A, Hiratsuka T, Shindo T, Horie A, Hamamoto T, Ueki N, Kusunoki M, Miyake K, Gudis K, Tsukui T, Sakamoto C: Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer. J Gastroenterol 2008; 43: 216-224.
30. Inoue T, Murano M, Abe Y, Morita E, Murano N, Yasumoto S, Toshina K, Nishikawa T, Maemura K, Hirata I, Katsu K: Therapeutic effect of nimesulide on colorectal carcinogenesis in experimental murine ulcerative colitis. J Gastroenterol Hepatol 2007; 22: 1474-1481.
31. Harris RE, Alshafie GA, Abou-Issa H, Seibert K: Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase-2 inhibitor. Cancer Res 2000; 60: 2101-2103.
32. Hu PJ, Yu J, Zeng ZR, Leung WK, Lin HL, Tang BD, Bai AH, Sung JJ: Chemoprevention of gastric cancer by celecoxib in rats. Gut 2004; 53: 195-200.
33. Futagami S, Suzuki K, Hiratsuka T, Shindo T, Hamamoto T, Tatsuguchi A, Ueki N, Shinji Y, Kusunoki M, Wada K, Miyake K, Gudis K, Tsukui T, Sakamoto C: Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils. Digestion 2006; 74: 187-198.
34. Futagami S, Hiratsuka T, Shindo T, Hamamoto T, Tatsuguchi A, Nobue U, Shinji Y, Suzuki K, Kusunoki M, Tanaka S, Wada K, Miyake K, Gudis K, Tsukui T, Sakamoto C: COX-2 and CCR2 induced by CD40 ligand and MCP-1 are linked to VEGF production in endothelial cells. Prostaglandins Leukot Essent Fatty Acids 2008; 78: 137-146.
35. Liang L, Hu D, Liu W, Williams JP, Okunieff P, Ding I: Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Am J Clin Oncol 2003; 26: 114-121.